Literature DB >> 34802542

Genetics of somatic auto-inflammatory disorders.

James A Poulter1, Sinisa Savic2.   

Abstract

Systemic autoinflammatory disorders (SAIDs) encompass a heterogeneous group of monogenic disorders characterized by recurrent episodes of systemic and organ-specific inflammation. Genetic studies have facilitated the identification of Mendelian forms of SAIDs but many patients still remain without a diagnosis. Recent studies have uncovered that somatic (acquired) mutations can cause later-onset SAIDs. In this review, we will discuss the current knowledge surrounding the genetics of these acquired auto-inflammatory disorders (AAIDs), with a focus on VEXAS, NLRP3-associated AAIDs and Schnitzler's syndrome and provide suggestions for future research in this field.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Auto-Inflammatory Disease; NLRP3; SAID; Schnitzler's syndrome; UBA1; VEXAS

Mesh:

Year:  2021        PMID: 34802542     DOI: 10.1053/j.seminhematol.2021.10.001

Source DB:  PubMed          Journal:  Semin Hematol        ISSN: 0037-1963            Impact factor:   3.851


  3 in total

Review 1.  Update on VEXAS and role of allogeneic bone marrow transplant: Considerations on behalf of the Chronic Malignancies Working Party of the EBMT.

Authors:  Carmelo Gurnari; Donal P McLornan
Journal:  Bone Marrow Transplant       Date:  2022-08-08       Impact factor: 5.174

Review 2.  Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic syndrome (VEXAS syndrome) with prominent supraglottic larynx involvement: a case-based review.

Authors:  Camila Andrea Guerrero-Bermúdez; Andrés Felipe Cardona-Cardona; Edwin Jesús Ariza-Parra; Juan Ignacio Arostegui; Anna Mensa-Vilaro; Jordi Yague; Gloria Vásquez; Carlos Horacio Muñoz-Vahos
Journal:  Clin Rheumatol       Date:  2022-08-20       Impact factor: 3.650

Review 3.  Improving Diagnosis and Clinical Management of Acquired Systemic Autoinflammatory Diseases.

Authors:  Adam Al-Hakim; Anoop Mistry; Sinisa Savic
Journal:  J Inflamm Res       Date:  2022-10-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.